Neuroprotective Effect of Methylene Blue in a Rat Model of Traumatic Optic Neuropathy
<b>Background</b>: Traumatic optic neuropathy (TON) represents a major cause of vision loss worldwide, and treatment options are limited. Here, we study whether methylene blue (MB), a free radical scavenger, is able to prevent morphological and electrophysiological hallmarks of neuropath...
Saved in:
| Main Authors: | Nicolás S. Ciranna, Ronan Nakamura, Rafael Peláez, Álvaro Pérez-Sala, Patricia Sarrión, Juan C. Fernández, Alejandra Paganelli, Agustín P. Aranalde, Ulises P. Ruiz, Juan J. López-Costa, César F. Loidl, Alfredo Martínez, Manuel Rey-Funes |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/6/920 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Methylene Blue Reduces Electroretinogram Distortion and Ganglion Cell Death in a Rat Model of Glaucoma
by: Ronan Nakamura, et al.
Published: (2024-09-01) -
Current Opportunities and Future Prospects of Neuroprotective Therapy in Glaucoma. Literature Review. Part 2
by: N. I. Kurysheva, et al.
Published: (2025-06-01) -
Current Opportunities and Future Prospects of Neuroprotective Therapy in Glaucoma. Literature Review. Part 1
by: N. I. Kurysheva, et al.
Published: (2025-03-01) -
Dendritic Branching of Retinal Ganglion Cells as a Biomarker of Glaucomatous Optic Neuropathy and Alzheimer’s Disease and a Target of Neuroprotective Therapy
by: M. V. Zueva, et al.
Published: (2022-10-01) -
Dendritic Branching of Retinal Ganglion Cells as a Biomarker of Glaucomatous Optic Neuropathy and Alzheimer’s Disease and a Target of Neuroprotective Therapy
by: M. V. Zueva, et al.
Published: (2021-07-01)